Skip to main content
99%+ PURITY VERIFIED·INDEPENDENT LAB TESTING·SHIPS WITHIN CANADA·DISCREET EXPRESS DELIVERY
JA Performance Peptides
JA Performance
Peptides
Back to Protocols
StackDSIPCJC-1295Ipamorelin

Sleep Protocol Stack — DSIP + CJC-1295 + Ipamorelin

Sleep, recovery & growth hormone stack protocol

Quick Reference

VIAL SIZEThree separate vials — DSIP, CJC-1295 (No DAC), Ipamorelin
RECONSTITUTIONDSIP: 1.0 mL BAC water · CJC-1295: 2.0 mL BAC water · Ipamorelin: 2.0 mL BAC water
CONCENTRATIONPer individual compound label
ROUTESubcutaneous injection
FREQUENCYAll three compounds once nightly, 30–60 minutes before sleep
CYCLE LENGTH8–12 weeks
DOSE RANGEDSIP: 100–300 mcg · CJC-1295: 100–300 mcg · Ipamorelin: 100–300 mcg
STORAGE−20 °C lyophilized / 2–8 °C reconstituted (use within 28 days)

Overview

The Sleep Protocol Stack combines DSIP, CJC-1295 (No DAC), and Ipamorelin to investigate the intersection of sleep quality, growth hormone secretion, and overnight recovery. DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide studied for its ability to promote slow-wave (delta) sleep and modulate circadian rhythm — research models have documented reduced sleep onset latency and improved sleep architecture. CJC-1295 (No DAC / Modified GRF 1-29) is a GHRH analogue that stimulates pituitary GH release with a ~30-minute active window, ideal for pre-sleep GH pulse amplification. Ipamorelin is a selective ghrelin mimetic (GHRP) that synergistically amplifies GH secretion through a distinct receptor, producing a clean GH pulse without significant cortisol or prolactin co-stimulation. Administered together 30–60 minutes before sleep, this stack targets deep sleep induction, overnight anabolic signalling, tissue repair, and body composition research models.

Dosing & Reconstitution Guide

PhaseDaily DoseUnitsVolume
Nightly (DSIP)100–300 mcg10–30 units (at ~1 mg/mL)0.10–0.30 mL
Nightly (CJC-1295)100–300 mcgPer vial concentrationPer vial concentration
Nightly (Ipamorelin)100–300 mcgPer vial concentrationPer vial concentration

Reconstitution Instructions

1.

Allow all three vials to reach room temperature.

2.

Reconstitute DSIP: draw 1.0 mL bacteriostatic water with a sterile syringe; inject slowly down the vial wall and swirl gently until dissolved.

3.

Reconstitute CJC-1295: draw 2.0 mL bacteriostatic water with a fresh syringe; inject slowly and swirl.

4.

Reconstitute Ipamorelin: draw 2.0 mL bacteriostatic water with a fresh syringe; inject slowly and swirl.

5.

Label each vial with the compound name and reconstitution date; refrigerate at 2–8 °C, protected from light. Use within 28 days.

This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

  • DSIP Vials: 2–4 vials (depending on vial mg size)
  • CJC-1295 (No DAC) Vials: 2–3 vials
  • Ipamorelin Vials: 2–3 vials
  • Insulin Syringes (U-100): 112 syringes
  • Bacteriostatic Water (10 mL): 1–2 bottles
  • Alcohol Swabs: 224 swabs

Dosing Protocol

Schedule

Administer all three compounds via subcutaneous injection 30–60 minutes before sleep. Fasting for 2–3 hours before injection maximises GH pulse amplitude — avoid carbohydrates and insulin-spiking foods in the pre-injection window.

DSIP Dosing

Start at 100 mcg nightly for weeks 1–2; titrate to 200–300 mcg based on sleep quality response and tolerance.

CJC-1295 + Ipamorelin Dosing

Begin both at 100 mcg each nightly; increase to 200–300 mcg each from week 3 if well-tolerated. CJC-1295 and Ipamorelin may be drawn into the same syringe for a single combined injection, administered separately from DSIP.

Cycle Structure

8–12 weeks on, followed by a 4-week off period. The rest period allows the GH axis to reset, maintaining pulse amplitude on resumption.

Storage & Handling

Important Notes